Aethlon Medical, Inc.

  • Home
  • The Hemopurifier®
    • The Hemopurifier® in Infectious Disease
    • The Hemopurifier® in Cancer
    • Resources
  • About
    • Overview
    • Exosome Sciences, Inc.
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Contact Us
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Outside Media
  • Investors
    • Overview
    • Corporate News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • IRS Form 8937
News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
  • Outside Media

Press Releases

May 17, 2022

Aethlon Medical to Present at the H.C. Wainwright Global Investment Conference

May 2, 2022

Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants

Mar 28, 2022

Aethlon Medical, Inc. Appoints Angela Rossetti to Board of Directors

Feb 14, 2022

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

Jan 31, 2022

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 14, 2022

Nov 9, 2021

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

Nov 2, 2021

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 9, 2021

Oct 12, 2021

Aethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of Critically Ill COVID-19 Patients Treated with the Hemopurifier®

Sep 30, 2021

Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical Programs

Sep 7, 2021

Aethlon Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...20
  • Twitter
  • Linkedin
  • YouTube
Privacy Policy Disclaimer Sitemap
© 2022 Aethlon Medical, Inc. All Rights Reserved.